- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 134031, 11 pages
Distinct Effects of Contraction-Induced Injury In Vivo on Four Different Murine Models of Dysferlinopathy
Department of Physiology, University of Maryland School of Medicine, 655 W. Baltimore Street, Baltimore, MD 21201, USA
Received 27 June 2011; Accepted 27 September 2011
Academic Editor: Aikaterini Kontrogianni-Konstantopoulos
Copyright © 2012 Joseph A. Roche et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. Bansal and K. P. Campbell, “Dysferlin and the plasma membrane repair in muscular dystrophy,” Trends in Cell Biology, vol. 14, no. 4, pp. 206–213, 2004.
- R. Han and K. P. Campbell, “Dysferlin and muscle membrane repair,” Current Opinion in Cell Biology, vol. 19, no. 4, pp. 409–416, 2007.
- L. Glover and R. H. Brown Jr., “Dysferlin in membrane trafficking and patch repair,” Traffic, vol. 8, no. 7, pp. 785–794, 2007.
- R. Bashir, S. Britton, T. Strachan et al., “A gene related to caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B,” Nature Genetics, vol. 20, no. 1, pp. 37–42, 1998.
- M. Vainzof, L. V. B. Anderson, E. M. McNally et al., “Dysferlin protein analysis in limb-girdle muscular dystrophies,” Journal of Molecular Neuroscience, vol. 17, no. 1, pp. 71–80, 2001.
- D. Bansal, K. Miyake, S. S. Vogel et al., “Defective membrane repair in dysferlin-deficient muscular dystrophy,” Nature, vol. 423, no. 6936, pp. 168–172, 2003.
- M. Ho, C. M. Post, L. R. Donahue et al., “Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency,” Human Molecular Genetics, vol. 13, no. 18, pp. 1999–2010, 2004.
- R. Hohlfeld, W. Müller, and K. V. Toyka, “Necrotizing myopathy in SJL mice,” Muscle and Nerve, vol. 11, no. 2, pp. 184–185, 1988.
- A. H. Weller, S. A. Magliato, K. P. Bell, and N. L. Rosenberg, “Spontaneous myopathy in the SJL/J mouse: pathology and strength loss,” Muscle and Nerve, vol. 20, no. 1, pp. 72–82, 1997.
- R. E. Bittner, L. V. B. Anderson, E. Burkhardt et al., “Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B,” Nature Genetics, vol. 23, no. 2, pp. 141–142, 1999.
- E. Vafiadaki, A. Reis, S. Keers et al., “Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation,” NeuroReport, vol. 12, no. 3, pp. 625–629, 2001.
- M. Von Der Hagen, S. H. Laval, L. M. Cree et al., “The differential gene expression profiles of proximal and distal muscle groups are altered in pre-pathological dysferlin-deficient mice,” Neuromuscular Disorders, vol. 15, no. 12, pp. 863–877, 2005.
- K. Kobayashi, T. Izawa, M. Kuwamura, and J. Yamate, “The distribution and characterization of skeletal muscle lesions in dysferlin-deficient SJL and A/J mice,” Experimental and Toxicologic Pathology, vol. 62, no. 5, pp. 509–517, 2010.
- W. M. Schmidt, M. H. Uddin, S. Dysek et al., “DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies,” PLoS Genetics, vol. 7, no. 4, Article ID e1002042, 2011.
- G. Cenacchi, M. Fanin, L. B. De Giorgi, and C. Angelini, “Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism,” Journal of Clinical Pathology, vol. 58, no. 2, pp. 190–195, 2005.
- W. Lostal, M. Bartoli, N. Bourg et al., “Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer,” Human Molecular Genetics, vol. 19, no. 10, pp. 1897–1907, 2010.
- J. A. Roche, R. M. Lovering, and R. J. Bloch, “Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo,” NeuroReport, vol. 19, no. 16, pp. 1579–1584, 2008.
- J. A. Roche, R. M. Lovering, R. Roche, L. W. Ru, P. W. Reed, and R. J. Bloch, “Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries,” American Journal of Physiology, vol. 298, no. 2, pp. C298–C312, 2010.
- D. P. Millay, M. Maillet, J. A. Roche et al., “Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy,” American Journal of Pathology, vol. 175, no. 5, pp. 1817–1823, 2009.
- R. M. Lovering, J. A. Roche, M. H. Goodall, B. B. Clark, and A. Mcmillan, “An in vivo rodent model of contraction-induced injury and non-invasive monitoring of recovery,” Journal of Visualized Experiments, no. 51, 2011.
- C. P. Ingalls, G. L. Warren, J. Z. Zhang, S. L. Hamilton, and R. B. Armstrong, “Dihydropyridine and ryanodine receptor binding after eccentric contractions in mouse skeletal muscle,” Journal of Applied Physiology, vol. 96, no. 5, pp. 1619–1625, 2004.
- S. S. Rabinowitz and S. Gordon, “Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli,” Journal of Experimental Medicine, vol. 174, no. 4, pp. 827–836, 1991.
- J. A. Roche, D. L. Ford-Speelman, L. W. Ru, et al., “Physiological and histological changes in skeletal muscle following in vivo gene transfer by electroporation,” American Journal of Physiology, Cell Physiology, vol. 301, no. 5, pp. C1239–C1250, 2011.
- G. R. Coulton, N. A. Curtin, J. E. Morgan, and T. A. Partridge, “The mdx mouse skeletal muscle myopathy: II. Contractile properties,” Neuropathology and Applied Neurobiology, vol. 14, no. 4, pp. 299–314, 1988.
- P. Sacco, D. A. Jones, J. R. T. Dick, and G. Vrbova, “Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle,” Clinical Science, vol. 82, no. 2, pp. 227–236, 1992.
- J. G. Quinlan, S. R. Johnson, M. K. McKee, and S. P. Lyden, “Twitch and tetanus in MDX mouse muscle,” Muscle and Nerve, vol. 15, no. 7, pp. 837–842, 1992.
- B. Weller, G. Karpati, and S. Carpenter, “Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions,” Journal of the Neurological Sciences, vol. 100, no. 1-2, pp. 9–13, 1990.
- C. Dellorusso, R. W. Crawford, J. S. Chamberlain, and S. V. Brooks, “Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury,” Journal of Muscle Research and Cell Motility, vol. 22, no. 5, pp. 467–475, 2001.
- S. I. Head, D. A. Williams, and D. G. Stephenson, “Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice,” Proceedings of the Royal Society B, vol. 248, no. 1322, pp. 163–169, 1992.
- J. Dangain and G. Vrbova, “Muscle development in mdx mutant mice,” Muscle and Nerve, vol. 7, no. 9, pp. 700–704, 1984.
- L. F. B. Torres and L. W. Duchen, “The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates,” Brain, vol. 110, no. 2, pp. 269–299, 1987.
- C. A. Mitchell, J. K. McGeachie, and M. D. Grounds, “Cellular differences in the regeneration of murine skeletal muscle: a quantitative histological study in SJL/J and BALB/c mice,” Cell and Tissue Research, vol. 269, no. 1, pp. 159–166, 1992.
- K. Nagaraju, R. Rawat, E. Veszelovszky et al., “Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B,” American Journal of Pathology, vol. 172, no. 3, pp. 774–785, 2008.
- C. A. Mitchell, M. D. Grounds, and J. M. Papadimitriou, “The genotype of bone marrow-derived inflammatory cells does not account for differences in skeletal muscle regeneration between SJL/J and BALB/c mice,” Cell and Tissue Research, vol. 280, no. 2, pp. 407–413, 1995.